Biocracked
**Approach 1: Macro science, Palette D: Bold color field**

Extreme macro photograph of a single human scalp hair strand, shot at a slight diagonal. It is pigmented dark brown at the root and fades into silvery-white along its length, with the cuticle scales and fine texture visible. Beside it, a few pure white strands cross the frame. The backdrop is a smooth, saturated mustard-yellow field with no pattern. A soft, wide key light from the upper left gives the strands a glossy, translucent sheen and a gentle shadow on the yellow. Shallow depth of field blurs the far end of the hair into creamy softness. One tiny electric green droplet of serum clings to the strand near the root, catching a bright highlight. The mood is crisp, curious and optimistic, with a scientific tone.
Supplements

Gashi Mai Grayi Ya Ragu da 13% a cikin Makonni 24 Ta Hanyar Hada Kwaya da Serum

Nova Chen · · 3 min read

Gashi Mai Grayi Ya Ragu da 13% a cikin Makonni 24 Ta Hanyar Hada Kwaya da Serum

Idan muka dubi gwajin da ya fi ba da mahimmanci ba ne yadda gashi ya inganta, sai dai yadda ƙungiyar placebo ta yi mummunan canji, za mu fahimci wani sabon yanayi. A cikin wani sabon gwaji mai tsari na ƙayyadaddun masu halarta, wanda aka yi masa randomized, double‑blind, mutanen da suka sha kwaya tare da amfani da serum sun ga adadin gashin toka ya ragu da 13.0% a cikin makonni 24. A gefe guda, mutanen da suka karɓi placebo biyu (kwaya da serum) sun ƙara da 9.7% na gashin toka.

Wannan bincike, da aka wallafa a Journal of Drugs in Dermatology (2026), yana da muhimmanci saboda marubutan sun bayyana cewa babu wani magani da aka taɓa nuna a gwajin kimiyya cewa yana mayar da gashi toka ko kuma yana rage saurin samunsa.

Matsalar: Grayi Ya Kusan Zama Gabaɗaya

Takaitaccen bayanin da ke cikin takarda ya nuna cewa a duniya, 74% na maza da mata masu shekaru 45 zuwa 65 suna da gashi toka aƙalla ɗan kaɗan. Duk da haka, masu bincike sun yi nuni da rashin wani magani da aka tabbatar da ingancinsa a gwaje‑gwajen kimiyya wajen dawo da launin gashi ko rage yawaitarsa. Kasuwa na cike da kayan launi da ke rufe gashi toka, ba su magance asalin matsalar ba.

Wannan tazara ce da gwajin ya yi ƙoƙarin cike ta, ta hanyar amfani da tsari mai matakai biyu daga kamfanin Two Lines Inc.: To The Root® serum (na shafa) da Not Today Grey (kwaya da ake sha).

Yadda Gwajin Aka Gine Shi

Tsarin gwajin ya fi karfi fiye da yawancin gwaje‑gwajen kayayyakin kasuwa:

  • Mutane 173 (maza da mata) daga shekaru 28 zuwa 65 suka kammala gwajin.
  • Dukkaninsu sun kasance da 5–25% na gashin toka a farkon gwajin, wato matakin farawa‑zuwa‑tsaka‑tsaki.
  • Gwajin ya kasance randomized, double‑blind, placebo‑controlled.
  • An gudanar da shi na makonni 24, tare da akalla mutane 40 a kowanne rukuni.

Rukunin gwajin su ne:

  1. Haɗin: kwaya + serum
  2. Kwaya kawai: kwaya + serum placebo
  3. Serum kawai: serum + kwaya placebo
  4. Placebo: kwaya placebo + serum placebo

Wannan tsari ne ya ba da damar tantance ko kowanne samfur zai iya aiki shi kaɗai ko kuma sai an haɗa su.

Lambobin Da Suka Fi Kawo Hankali

Sakamakon Rukuni Na Haɗin

  • Mako 12: ragin gashi toka 9.2% (P = 0.034 idan aka kwatanta da farko).
  • Mako 24: ragin gashi toka 13.0% (P = 0.016 idan aka kwatanta da farko).

Sakamakon Rukuni Na Placebo

  • Adadin gashi toka ya tashi 9.7% daga farko zuwa mako 24.
  • Idan aka kwatanta rukuni na haɗin da placebo a mako 24, P = 0.004, wato bambanci mai mahimmanci ta fuskar ƙididdiga.

Masu binciken sun bayyana cewa wannan ragi ba kawai ya wuce gwajin ƙididdiga ba, har ma ya daɗa da ma’anar kiwon lafiya ga masu shan haɗin.

Abin Da Za a Iya Sanya Hankali

  • Haɗin kwaya da serum ne ke haifar da sakamakon – ba kowane samfur ɗaya ke da tasiri ba.
  • Sakamakon yana nuna clinical relevance: mutane da suka yi amfani da haɗin sun ga gashinsu yana ƙara launi da kuma rage yawaitar toka.
  • Wannan ya nuna buƙatar ƙarin gwaje‑gwaje masu tsawo da manyan ƙungiyoyi don tabbatar da sahihancin sakamakon a al’umma.

Me Zai Iya Amfana?

  • Mutanen da ke da gashi toka a matakin farawa‑zuwa‑tsaka‑tsaki (5‑25%).
  • Wadanda ke neman magani mai inganci wanda ba launi kawai ba, har ma da mayar da launin gashi.

Kammalawa

Binciken ya ba da haske kan yadda haɗin supplement da serum zai iya rage gashi toka a cikin makonni 24, yayin da placebo ke ƙara yawaitar gashi toka. Duk da cewa an ga tasiri mai mahimmanci a cikin rukuni na haɗin, ana buƙatar ƙarin bincike don tantance ko za a iya amfani da wannan tsari a matsayin magani na dindindin ga al’umma.

Original study

Read the original research on pubmed.ncbi.nlm.nih.gov →

This article summarizes published research for general information. It is not medical advice.

NC

Written by

Nova Chen

Nova Chen writes for Biocracked: biohacking science, longevity & human performance.

Related Articles

Approach: the human outcome. Palette: natural.

Extreme close-up of a woman's eye and the delicate skin around it, shot from a slight three-quarter angle with a 100mm macro lens and a shallow depth of field. Her skin is a mature 50s complexion with fine crow's feet that are sharp and tactile, with visible pores and soft vellus hairs. Her gaze is relaxed and not at the camera, and the face is cropped so identity isn't the focus. Soft, directional window daylight rakes across the skin from the left to bring out the wrinkle texture, with gentle warm skin tones and a blurred leafy green background outdoors. A single glass of water with a faint dissolving powder swirl sits out of focus in the foreground, with a tiny electric green leaf highlight at the edge. The mood is calm, honest and quietly scientific.
peptides

Gram 2.5 na Peptide Collagen Ya Rage Tabon Idanu da Kashi 20% Cikin Makonni 8

BY NOVA CHEN ·

Collagen ɗaya daga manyan abubuwan da ake nema a fannin kwalliya da tsawon rai, amma mafi yawan samfuran suna da takardun placebo ne kawai. A wani gwaji da mata 114 masu shekaru 45‑65 suka halarta, gram 2.5 na takamaiman peptide mai aiki Verisol ya rage ƙyallin tabon idanu da kashi 20 % idan aka kwatanta da placebo bayan makonni 8. Biopsies sun nuna ƙaruwa a procollagen I da kashi 65 % da elastin da kashi 18 %, yayin da ƙaruwa a fibrillin (6 %) ba ta da muhimmanci.

**Approach: Human outcome. Palette: warm (B).**

Extreme close-up, slightly high angle, of a woman's scalp parting in her 40s. Dense, glossy chestnut-brown hair is split by a fine comb. Short new hairs rise from the visible scalp skin, and a few strands catch the light. Faces and identity are out of frame. Low golden-hour window light enters from camera left and rim-lights the strands in honey and copper. Shadows stay warm brown, with no blue cast. The shallow depth of field blurs the background hair into soft amber bokeh. A thin steel trichoscopy probe tip sits at the edge of the frame, and a tiny electric green LED glints on its housing as the only accent. The mood is hopeful but scrutinizing, like a clinical check-up with a cautious eye.
supplements

NMN Ya Kara Yawan Gashi da Kashi 57% a Binciken Dan Adam—Amma Tare da Manyan Matsaloli

BY NOVA CHEN ·

NMN, sinadarin da ke ƙara matakin NAD+ da masu sha'awar tsawon rai ke nema, an gwada shi a kan gashi a mutane a karon farko. A cikin gwaji na makonni 12 da ya ƙunshi mata 15 masu shekaru 40‑50, yawan gashin da ke cikin yanayin haɓaka ya tashi daga 55.9 zuwa 87.7 gashi/cm², kuma kaurin gashi ya karu daga 75.3 zuwa 78.8 µm. Masu halarta sun kuma ba da rahoton ƙarin sheki, lankwasa, da girma. Amma ba a samu rukunin placebo ba, samfurin da aka yi amfani da shi ya yi ƙanƙanta, kuma marubutan suna da alaƙa da mai samar da NMN. Ga abin da lambobin ke nuna, abin da ba za su iya tabbatar ba, da kuma abubuwan da ya kamata a jira.

Approach: conceptual metaphor. Palette: D, bold color field.

A single brass dial-style dosing syringe-free metaphor: a tall glass measuring cylinder, photographed straight on at eye level, filled with clear liquid and a column of stacked white tablets that rises in even steps and then stops short of a thin painted line, as if a staircase of doses has been held back. The glass cylinder stands on a glossy surface against a saturated tomato-red seamless backdrop. Soft large-softbox light from the left gives crisp highlights on the glass and a clean, short shadow on the right. A tiny electric green (#00e676) rubber band circles the cylinder near the top limit. Shallow depth of field blurs a second, taller cylinder in the background. Mood: controlled, restrained, quietly hopeful. No text, no markings legible.
supplements

Shin Magtein Na Rage Ƙaruwa na Dawa Opioid a Cikin Majinyatan Ciwon Daɗi? Abinda Binciken Ya Gano

BY NOVA CHEN ·

Magnesium‑L‑threonate, da aka fi sani da Magtein, an gwada shi a cikin majinyata 83 masu ciwon daɗi na mataki na ƙarshe da ke shan opioid a baki. Sakamakon ya nuna cewa adadin morphine da suke buƙata ya ragu kusan rabi idan aka ƙara Magtein a cikin magani, kuma ƙananan kumburin ciki da opioid ke haifarwa sun ragu. Amma wannan ƙaramin gwaji ne a asibiti guda a China, ba dalili ba ne na canza magani ba tare da shawarar likita ba.

Approach: conceptual metaphor. Palette: D, bold color field.

A single AA-style cylindrical battery stands upright, fully charged, on a seamless saturated mustard-yellow backdrop. Beside it sits a matching, untouched, slightly dusty glass jar of marbles, so the charge shows no visible link to any result. More precisely, a bright tomato-red extension cord plugs into the battery's top. Its other end curls away unconnected, lying on the floor beside an unlit incandescent bulb. A small electric green LED glows on the battery's side as the only green accent. Camera: low three-quarter angle, 50mm lens, shallow depth of field, with the bulb softly blurred in the foreground. Lighting: hard, clean studio key light from the upper left, with crisp shadows falling to the right on the yellow surface. Mood: puzzled, wry, a full power source that fails to light anything.
supplements

Nicotinamide Riboside Ya Ƙara NAD+, Amma Bai Inganta Tunawa ba

BY NOVA CHEN ·

Wani ƙara ya ninka matakin NAD+ a jini, amma ba a samu tasiri a kan tunawa ba. A gwajin makonni 12 da aka gudanar kan manya da ke da amnestic mild cognitive impairment (aMCI), nicotinamide riboside ya ninka NAD+ sau biyu, amma ba ya haɓaka aikin kwakwalwa, yawan jinin kwakwalwa, ko hawan jini. An ga alamar ƙaruwa a yawan jinin da ke gudana zuwa hippocampus, amma wannan ba tabbataccen sakamako ba ne. Ga abin da binciken ya nuna, iyakokinsa, da abin da ya ke nufi ga waɗanda ke tunanin ƙara NAD+.

This page is available in